ZA974978B - Formulation and method for treating congestive heart failure - Google Patents

Formulation and method for treating congestive heart failure

Info

Publication number
ZA974978B
ZA974978B ZA974978A ZA974978A ZA974978B ZA 974978 B ZA974978 B ZA 974978B ZA 974978 A ZA974978 A ZA 974978A ZA 974978 A ZA974978 A ZA 974978A ZA 974978 B ZA974978 B ZA 974978B
Authority
ZA
South Africa
Prior art keywords
formulation
heart failure
congestive heart
treating congestive
treating
Prior art date
Application number
ZA974978A
Other languages
English (en)
Inventor
John Leeper Mcnay
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA974978B publication Critical patent/ZA974978B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA974978A 1996-06-06 1997-06-05 Formulation and method for treating congestive heart failure ZA974978B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65946396A 1996-06-06 1996-06-06

Publications (1)

Publication Number Publication Date
ZA974978B true ZA974978B (en) 1998-12-07

Family

ID=24645503

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA974978A ZA974978B (en) 1996-06-06 1997-06-05 Formulation and method for treating congestive heart failure

Country Status (17)

Country Link
EP (1) EP0914128A1 (fr)
JP (1) JP2000511906A (fr)
KR (1) KR20000016406A (fr)
CN (1) CN1226166A (fr)
AU (1) AU3233197A (fr)
BR (1) BR9709546A (fr)
CA (1) CA2256720A1 (fr)
CZ (1) CZ397698A3 (fr)
EA (1) EA199900006A1 (fr)
HU (1) HUP0003885A2 (fr)
IL (1) IL126966A0 (fr)
NO (1) NO985695L (fr)
PL (1) PL330637A1 (fr)
TR (1) TR199802496T2 (fr)
WO (1) WO1997046241A1 (fr)
YU (1) YU55998A (fr)
ZA (1) ZA974978B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19815411A1 (de) * 1998-04-06 1999-10-07 Solvay Pharm Gmbh Thermogenese stimulierend wirksame Arzneimittel
WO2000044355A1 (fr) * 1999-01-29 2000-08-03 Eli Lilly And Company Sels de moxonidine
ES2235829T3 (es) * 1999-02-01 2005-07-16 Solvay Pharmaceuticals Gmbh Utilizacion de moxonidina para el tratamiento post-infarto de corazon.
EP1894927B1 (fr) * 2006-08-31 2010-11-10 Chemagis Ltd. Utilisation des sels de moxonidine pour la purification de monoxidine
KR100812287B1 (ko) * 2007-01-03 2008-03-13 주식회사 챠콜코리아 내면에 반사층을 갖는 신호등 갓

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4323570A (en) * 1978-11-15 1982-04-06 Beiersdorf Aktiengesellschaft Substituted aminopyrimidines
DE3617158C2 (de) * 1986-05-22 1994-10-06 Lohmann Therapie Syst Lts Transdermales Arzneimittel
DE3729299A1 (de) * 1987-09-02 1989-03-23 Beiersdorf Ag Transdermales therapeutisches system
DE3904795C2 (de) * 1989-02-17 2000-10-12 Lilly Pharma Produktion Gmbh & Pharmazeutisches Präparat und dessen Verwendung
DE4325491A1 (de) * 1993-07-29 1995-02-02 Boehringer Ingelheim Kg Verwendung von zentral wirksamen alpha-2-Agonisten zur Hemmung des Postaggressionsstoffwechsels
DE4423177A1 (de) * 1994-07-01 1996-01-04 Kali Chemie Pharma Gmbh Antihyperglykämisch wirksame Arzneimittel
CA2182851A1 (fr) * 1995-08-15 1997-02-16 August Masaru Watanabe Methode de traitement d'un etat resultant de l'arret de la consommation abusive de drogues

Also Published As

Publication number Publication date
NO985695L (no) 1999-02-04
AU3233197A (en) 1998-01-05
WO1997046241A1 (fr) 1997-12-11
TR199802496T2 (xx) 1999-02-22
CZ397698A3 (cs) 1999-05-12
PL330637A1 (en) 1999-05-24
YU55998A (en) 1999-11-22
EA199900006A1 (ru) 1999-06-24
EP0914128A1 (fr) 1999-05-12
HUP0003885A2 (hu) 2001-04-28
KR20000016406A (ko) 2000-03-25
JP2000511906A (ja) 2000-09-12
CN1226166A (zh) 1999-08-18
BR9709546A (pt) 1999-08-10
IL126966A0 (en) 1999-09-22
NO985695D0 (no) 1998-12-04
CA2256720A1 (fr) 1997-12-11

Similar Documents

Publication Publication Date Title
EP1007152A4 (fr) Methode et appareil de traitement de l'arythmie cardiaque
IL128545A0 (en) Method for treating and preventing heart failure and ventricular dilatation
AU2531297A (en) Method and apparatus for rate-responsive cardiac pacing
IL131821A0 (en) Defibrillator apparatus and method
AU2543097A (en) Method for treating pain
AU2587297A (en) Method for treating pain
ZA97947B (en) Method and apparatus for applying tissue seaplant.
AU7568698A (en) Method and apparatus for dermatology treatment
AU5242698A (en) Method of pressure treating boards
IL129272A0 (en) Method and composition for treating skin damage
GB9617780D0 (en) Method of treatment
HU9900386D0 (en) Method for treating heart failure
GB9511889D0 (en) Compensation method and apparatus
HK1020638A1 (en) Dc offset compensation method and apparatus
AU4419297A (en) Method and apparatus for web treatment
GB9605828D0 (en) Treatment method
AU2340897A (en) Method for treating pain
PL328964A1 (en) Acne treating method
IL126966A0 (en) Formulation and method for treating congestive heart failure
ZA973988B (en) Method of treatment
GB9618341D0 (en) Method of treatment
IL125762A0 (en) Method for treating heart failure
AU2769497A (en) Therapy apparatus and method
AU2492297A (en) Method for treating congestive heart failure
HU9903735D0 (en) Method for treating congestive heart failure